Feasibility of Continuous Noninvasive Finger Arterial Blood Pressure Measurement for Detection and Staging of Aortic Stenosis
NCT ID: NCT03088787
Last Updated: 2018-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2017-04-01
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Arterial Stiffness, Blood Pressure and Cardiac Output Study
NCT03469388
Development of Ultra-Low Dose CT Based Screening for Aortic Aneurysms
NCT03479164
Impact of Aortic Geometry on Vascular Remodeling After Stent Implantation in Coarctation of the Aorta
NCT07131111
Non-invasive Aortic Aneurysm Tissue Characterization Using Wall Viscoelasticity
NCT04150653
The Effect of Surgery on Central Aortic Pressure & haEmodynamics Study
NCT02493296
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients for TAVR
Patients for TAVR
Nexfin measuremtents
There will be only observational recordings, no interevntion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nexfin measuremtents
There will be only observational recordings, no interevntion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical team agrees on eligibility including assessment that TAVR is appropriate for the subject
* Patients undergoing TAVR via the femoral approach
* Patients who normally require a guiding catheter for central aortic pressure monitoring during the TAVR procedure
* Patient must be 18 years old or older
* Patient, or legally authorized representative, has given consent to be in the study
* Patient height and weight are available prior to study
* Ability to perform a Nexfin measurement at the left hand side.
Exclusion Criteria
* Patients with mixed aortic valve disease (aortic stenosis and aortic regurgitation with predominant aortic regurgitation \>3+).
* Aortic valve is a congenital unicuspid or congenital bicuspid valve, or is noncalcified
* Patients being treated with an intra-aortic balloon pump
* Patients less than 40 kg in weight
* Female patients of childbearing potential with a known pregnancy
* Patient is currently participating in an investigational drug or another device study that clinically interferes with the study endpoints
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Edwards Lifesciences
INDUSTRY
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
D.P.Veelo
MD PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Veelo
Amsterdam, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Kho E, Schenk J, Vlaar APJ, Vis MM, Wijnberge M, Stam LB, van Mourik M, Jorstad HT, Hermanns H, Westerhof BE, Veelo DP, van der Ster BJP. Detecting aortic valve stenosis based on the non-invasive blood pressure waveform-a proof of concept study. Geroscience. 2024 Dec;46(6):5955-5965. doi: 10.1007/s11357-024-01136-w. Epub 2024 Mar 20.
Schenk J, Kho E, Rellum S, Kromhout J, Vlaar APJ, Baan J, van Mourik MS, Jorstad HT, van der Ster BJP, Westerhof BE, Bruns S, Immink RV, Vis MM, Veelo DP. Immediate reduction in left ventricular ejection time following TAVI is associated with improved quality of life. Front Cardiovasc Med. 2022 Sep 16;9:988840. doi: 10.3389/fcvm.2022.988840. eCollection 2022.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
W17_072
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.